A recent piece published by our McGuireWoods colleagues Nathan Kottkamp and Lauren Ramos is a good reminder for investors about the real risk of HIPAA violations.

HIPAA violations are among the most frequent issues we see in healthcare private equity deal diligence, and we are very comfortable taking a practical and realistic approach to rectifying the noncompliance.

To access the column, click here.